U.S. advisers say keep Glaxo's Avandia on market
Wednesday, July 14, 2010 - 15:56
in Psychology & Sociology
U.S. health advisers said GlaxoSmithKline Plc's GSK.L diabetes drug Avandia should be allowed to stay on the market in some form, easing a threat of further litigation that could have followed a ban.